Genetic research

Genetic research

Breakthrough in Sepsis Research: Identifying Biomarkers and Therapeutic Targets

Researchers from Sichuan University have made significant advancements in understanding the pathogenesis of severe sepsis, a systemic inflammatory response syndrome that predisposes to severe lung infections. Through a comprehensive bioinformatics approach, the study aimed to unravel the underlying mechanisms of sepsis-associated acute lung injury (Se/ALI) and sepsis-associated acute respiratory

Genetic research

Genetic Variation in Pluripotent Stem Cells Influences Gene Regulation in Regenerative Medicine

New research by investigators from Jackson Laboratory has found that genetic variation in pluripotent stem cells leads to phenotypic variability, challenging regenerative medicine. The study, published in G3: Genes, Genomes, Genetics, aimed to investigate how genetic variants affecting the pluripotent state influence gene regulation later in development. The researchers characterized

Genetic research

Nanoparticles Show Promise in Cancer Gene Therapy for Hematological Malignancies

Research at the Department of Hematology and Blood Banking has shown that nanoparticles, particularly nanotechnology, hold transformative potential in the treatment of hematological malignancies, such as leukemia, lymphoma, and multiple myeloma. Despite limitations in conventional therapies, nanomedicine offers more effective and specific therapies by enhancing drug delivery and reducing toxicity.

Genetic research

Advances in Cancer Gene Therapy: Researchers Develop Novel Approach to Deliver Bone Morphogenetic Proteins to Glioma Tumors

Recent studies have made significant strides in developing cancer gene therapy, particularly in the delivery of Bone Morphogenetic Proteins (BMPs) to glioma tumors. Researchers from the Department of Pharmacy have identified the potential of BMPs in differentiating glioma cells, inhibiting tumor growth, and managing glioma stem cells. However, the clinical

Genetic research

Axitinib's Mechanism of Action in Metastatic Renal Cell Carcinoma Revealed

Scientists at Istanbul Technical University have conducted a comprehensive study on the interactions between Axitinib, a second-generation tyrosine kinase inhibitor, and DNA. Their research aimed to shed light on the pharmacodynamic properties of Axitinib and explore the possibility of developing more effective DNA-binding therapeutics. Through various analytical techniques, including UV-Vis